Clinical trial
A Phase 1/2 Study of BA3071 in Patients With Solid Tumors
NCT05180799 is registered in ClinicalTrials.gov with BioAtla, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 1/2 Study of BA3071 in Patients With Solid Tumors
- Lead sponsor
- BioAtla, Inc.
- Phase
- Phase 1/2
- Overall status
- Active, not recruiting
- Start date
- August 3, 2022
- Completion date
- June 30, 2026
- Enrollment
- 320 (estimated)
- Sites
- 12
Conditions
As the registry lists them; a condition with its own page is linked.
melanoma, nsclc